Delivery Order 75F40119D10024-75F40119F19001
Award Date
9/12/19
Potential Completion Date
9/11/21
Potential Value
$336K
Federal Agency
Food and Drug Administration
Ultimate Awardee
Pharmaron (Exton) Lab Services LLC
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92111, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $281,500.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA) to Physical Pharmaceutica LLC, a for-profit limited liability company, for the investigation of release rates and factors affecting release rate tests of cyclosporine from ophthalmic emulsions using pulsatile microdialysis. The contract has an ultimate completion date of January 15, 2018 and does not have a set-aside designation. The contract is part of the FDA's broader program focused on the...
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $17,267 purchase order to Pharmaron (Exton) Lab Services LLC, doing business as Absorption Systems, for testing services. The firm fixed price contract has a period of performance from August 23, 2016 to September 30, 2016 for work to be conducted in Bethesda, Maryland. No additional details were provided regarding the scope of testing services...
This is a firm fixed-price purchase order award from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Pharmaron, Inc. The $78,300.00 contract is for testing compounds to evaluate their ability to block cardiac ion channels, which is relevant to drug discovery and development. Pharmaron is a global contract research organization (CRO) that specializes in preclinical research services, including pharmacokinetics,...
This federal contract award from the Defense Logistics Agency Troop Support Medical provides for the delivery of 60 units of 0.05% cyclosporine ophthalmic emulsion under a firm fixed price delivery order valued at $542.97. The prime contractor, Amerisourcebergen Drug Corp Corporate Office Division, will perform the order from its place of performance in Conshohocken, Pennsylvania. Funding is provided by DLA Troop Support Medical to support its medical supply needs. As a delivery order under an...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,641.14 firm fixed-price contract is for the delivery of 4566848595 - Cyclosporine 0.05% Eye Emulsion 30s, a prescription eye medication. This delivery order is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor, to provide Cyclosporine 0.05% eye emulsion. The $4,924.16 firm fixed price delivery order has an ultimate completion date of March 20, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor. The award is part of a larger indefinite delivery contract (IDC) issued by DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $21,236.91 firm-fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a medication used to treat dry eye disease. The award is not associated with any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
The Defense Logistics Agency awarded a $35,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 units of 0.05% cyclosporine ophthalmic emulsion. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order is for an immunosuppressive drug commonly used to treat ocular surface disease and was issued under an existing DLA contract vehicle. As a leading pharmaceutical distributor, Amerisourcebergen will deliver...
This firm fixed-price purchase order contract, valued at $54,000.00, was awarded by the National Center for Advancing Translational Sciences (NCATS), a division of the National Institutes of Health (NIH), to Pharmaron, Inc. Pharmaron is a minority-owned, for-profit Subcontinent Asian (Asian-Indian) American contract research organization that specializes in preclinical drug discovery and development services. The contract is for testing 20 small molecule compounds in rat pharmacokinetic...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,073.53 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 12, 2023, with a completion date of September 13, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC...